5-fluorouracil cardiotoxicity is increasingly recognized with variable
presentation. We report a patient who developed cardiogenic shock due
to high-dose B-fluorouracil infusion (1,000 mg/m(2) every 24 hr for 9
6 hr). There was no evidence of myocardial necrosis, The patient recov
ered completely without any residual cardiac dysfunction. The exact ca
use of 5-fluorouracil toxicity remains to be determined. The case high
lights the need for careful monitoring of patients who receive high-do
se 5-fluorouracil for the development of cardiotoxicity.